Carnyx Therapeutics Leadership to Contribute Insights at Dubai's Healthy Ageing Summit
Carnyx Therapeutics Ltd., a pioneering company in the biopharmaceutical sector, is preparing to make a notable impact at the forthcoming Healthy Ageing Summit in Dubai. Scheduled for November 25, 2026, this prestigious event will feature keynote speeches and expert panels focused on enhancing human longevity and health, particularly through the lens of sleep science.
The summit will see Prof. Patrick Gunning, CEO and Co-Founder of Carnyx, delivering a keynote address entitled "The Science of Sleeping: How Better Sleep Extends Healthspan." This presentation aims to delve into the vital connection between sleep and the aging process, shedding light on how quality sleep can enhance overall health and longevity. Prof. Gunning emphasizes, "Sleep is one of the most fundamental aspects of human health, and its importance to healthy aging is becoming increasingly clear."
Joining him will be Dr. Mark Lindsay, the Chief Innovation Officer and Co-Founder of Carnyx, who boasts over 35 years of experience in neuroscience and athletics. Dr. Lindsay will participate in a panel dedicated to discussing human health, performance, and metabolic function. His extensive background with elite athletes provides him with unique insights into the critical role sleep plays in physical recovery and long-term health. He states, "Working with elite athletes for more than 35 years has shown me how important sleep is to recovery, performance, and long-term health. Understanding how sleep and physical function change with age has important implications for helping people remain healthy and active throughout their lives."
The Healthy Ageing Summit will bring together industry leaders from healthcare, investment, and innovation sectors. During this gathering, Carnyx's leadership team plans to engage with potential investors and clinical collaborators. This effort highlights the company's commitment to forging meaningful partnerships that can advance their mission of developing next-generation molecular therapeutics. Interested parties can connect with the Carnyx team in Dubai by reaching out via the provided contact email.
This summit follows the recent public unveiling of Carnyx's investigational sleep candidate, CNYX-005, which showed promising results in preclinical studies involving aged rats. The findings indicated a significant increase in total sleep time – approximately 1.5 to 2 hours longer than that of the control group, primarily attributed to enhanced non-rapid eye movement (NREM) sleep as measured by continuous electroencephalography (EEG) monitoring. Prof. Gunning remarked, "Advances in sleep science are creating opportunities to develop new therapeutic approaches to age-related changes in sleep."
NREM sleep plays a crucial role in restorative processes within the body, making it a critical focus for those studying the intersection of sleep and health. CNYX-005 is a unique candidate developed from research into peptide biology, specifically looking at compounds such as Epitalon which are believed to contribute to improved sleep quality.
Carnyx Therapeutics represents a beacon of innovation in the biopharmaceutical landscape, and its participation in the Healthy Ageing Summit is a testament to its strategic vision. The company is eager to share its research and findings that have broad implications for both clinical practices and the science of aging. As we move forward in an era that increasingly values longevity and quality of life, Carnyx's advancements in sleep therapeutics stand to benefit many individuals seeking to enhance their health as they age.
For more information or to register for the Healthy Ageing Summit, please visit the summit's official site or learn more about Carnyx Therapeutics at their official website.
In sum, the contributions of Carnyx Therapeutics at the upcoming summit aim not only to illuminate the importance of sleep in promoting a healthier lifespan but also to catalyze discussions that may lead to groundbreaking innovations in the approach we take towards aging and health today.
The summit will see Prof. Patrick Gunning, CEO and Co-Founder of Carnyx, delivering a keynote address entitled "The Science of Sleeping: How Better Sleep Extends Healthspan." This presentation aims to delve into the vital connection between sleep and the aging process, shedding light on how quality sleep can enhance overall health and longevity. Prof. Gunning emphasizes, "Sleep is one of the most fundamental aspects of human health, and its importance to healthy aging is becoming increasingly clear."
Joining him will be Dr. Mark Lindsay, the Chief Innovation Officer and Co-Founder of Carnyx, who boasts over 35 years of experience in neuroscience and athletics. Dr. Lindsay will participate in a panel dedicated to discussing human health, performance, and metabolic function. His extensive background with elite athletes provides him with unique insights into the critical role sleep plays in physical recovery and long-term health. He states, "Working with elite athletes for more than 35 years has shown me how important sleep is to recovery, performance, and long-term health. Understanding how sleep and physical function change with age has important implications for helping people remain healthy and active throughout their lives."
The Healthy Ageing Summit will bring together industry leaders from healthcare, investment, and innovation sectors. During this gathering, Carnyx's leadership team plans to engage with potential investors and clinical collaborators. This effort highlights the company's commitment to forging meaningful partnerships that can advance their mission of developing next-generation molecular therapeutics. Interested parties can connect with the Carnyx team in Dubai by reaching out via the provided contact email.
This summit follows the recent public unveiling of Carnyx's investigational sleep candidate, CNYX-005, which showed promising results in preclinical studies involving aged rats. The findings indicated a significant increase in total sleep time – approximately 1.5 to 2 hours longer than that of the control group, primarily attributed to enhanced non-rapid eye movement (NREM) sleep as measured by continuous electroencephalography (EEG) monitoring. Prof. Gunning remarked, "Advances in sleep science are creating opportunities to develop new therapeutic approaches to age-related changes in sleep."
NREM sleep plays a crucial role in restorative processes within the body, making it a critical focus for those studying the intersection of sleep and health. CNYX-005 is a unique candidate developed from research into peptide biology, specifically looking at compounds such as Epitalon which are believed to contribute to improved sleep quality.
Carnyx Therapeutics represents a beacon of innovation in the biopharmaceutical landscape, and its participation in the Healthy Ageing Summit is a testament to its strategic vision. The company is eager to share its research and findings that have broad implications for both clinical practices and the science of aging. As we move forward in an era that increasingly values longevity and quality of life, Carnyx's advancements in sleep therapeutics stand to benefit many individuals seeking to enhance their health as they age.
For more information or to register for the Healthy Ageing Summit, please visit the summit's official site or learn more about Carnyx Therapeutics at their official website.
In sum, the contributions of Carnyx Therapeutics at the upcoming summit aim not only to illuminate the importance of sleep in promoting a healthier lifespan but also to catalyze discussions that may lead to groundbreaking innovations in the approach we take towards aging and health today.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.